Yıl: 2016 Cilt: 25 Sayı: 1 Sayfa Aralığı: 52 - 58 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients

Öz:
AMAç: Metabolik Sendrom (MetS) kardiyovasküler hastalık riskini artıran bir endokrinopatidir. Nabız Dalga Hızı (NDH) ve Augmentasyon İndeksi (Alx) ölçümleri ile değerlendirilen arteriyel sertlik kardiyovasküler hastalık risk belirlenmesinde sıklıkla kullanılmaktadır. Çalışmamızda periton diyaliz hastalarındaki MetS sıklığını ve arteriyel sertlik durumlarını değerlendirmeyi amaçladık.Gereç ve yÖNTeMler: Çalışmaya 36 periton diyalizi hastası alındı. Hastaların bel çevresi, Vücut kitle indeksi (VKİ), kan basıncı, glukoz, Trigliserid, HDL-Kolesterol değerleri kaydedildi. Nabız dalga hızı ve Alx ölçümleri Mobil-O-Graph cihazı ile yapıldı. Metabolik Sendrom tanısında, Adult Treatment Panel III ölçütleri kullanıldı.BulGulAr: Periton diyalizi hastalarının %47,2'sinde MetS saptandı ve 55 yaş üstünde sıklığı %61 bulundu. MetS grubunda VKİ, bel çevresi, glikoz, trigliserid düzeyleri yüksekti. MetS grubu ortanca yaşı anlamlı yüksekti (p=0,044). Yaş ile düzeltilmiş analizde Alx@75 MetS grubunda anlamlı yüksek saptandı (p=0,025), fakat NDH'ında anlamlı fark saptanmadı. Regresyon analizinde NDH'nın bağımsız belirleyicileri yaş, santral sistolik kan basıncı ve augmentasyon basıncı olduğu saptandı. SONuç:Metabolik sendrom sıklığı %47,2'dir ve55yaşüstünde dahayaygındır. Alx@75 değerleri MetS grubunda anlamlı yüksektir.
Anahtar Kelime:

Konular: Cerrahi

Periton Diyalizi Hastalarında Metabolik Sendrom ve Arteriyel Sertlik

Öz:
OBJeCTIVe: The metabolic syndrome (MetS) is an endocrinopathy that increases the risk of cardiovascular disease. Arterial stiffness is commonly used to evaluate the risk of cardiovascular disease, which is quantified by pulse wave velocity (PWV) and augmentation index (AIx). Our study aim was evaluate the prevalence of MetS and arterial stiffness in peritoneal dialysis patients MATerIAl and MeTHODS: A total of 36 peritoneal dialysis patients were included. Patients' waist circumference, body mass index (BMI), blood pressure, glucose, triglyceride, andHDL-cholesterol levels were recorded. PWV andAIxmeasurements were performed bymeans oftheMobil-O-Graph device. Adult Treatment Panel III criteria were used for the diagnosis of MetS.reSulTS: 47.2% of peritoneal dialysis patients had MetS, and the prevalence of MetS was found to be 61% above the age of 55 years. Patients with MetS had higher BMI, waist circumference, glucose, triglyceride levels. Median agewassignificantly higher intheMetS group (p=0.044). Age-adjusted analysis revealed significantly higher Alx@75 in theMetS group (p=0.025); butnosignificant difference wasobserved in PWV. Inregression analysis, theage,central systolic blood pressure, and augmentation pressure appeared as the independent determinants of PWV.CONCluSION: Metabolic Syndrome prevalence was found to be 47.2%, and it was more common in subjects older than55years. IntheMetS group, theAlx@75 values were found to besignificantly higher
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438
  • Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M: Metabolic syndrome and renal disease. Int J Cardiol 2013;164:141- 150
  • Singh AK, Kari JA: Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013;22:198-203
  • Park SH, Lindholm B: Definition of metabolic syndrome in peritoneal dialysis. Perit Dial Int 2009;29:S137-144
  • Shirwany NA, Zou M: Arterial stiffness: A brief review. Acta Pharmacol Sin 2010;31:1267-1276
  • Kangas P, Tikkakoski AJ, Tahvanainen AM, Leskinen MH, Viitala JM, Kähönen M, Kööbi T, Niemelä OJ, Mustonen JT, Pörsti IH: Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: A study in 84 cases and 82 controls. Metabolism 2013;62:1114-1122
  • Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J: The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis. J Clin Endocrinol Metab 2009;94:2893-2899
  • Chan DT, Watts GF, Irish AB, Ooi EM, Dogra GK: Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease. Am J Hypertens 2013;26:1155-1161
  • Brillante DG, O'Sullivan AJ, Howes LG: Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin ii receptors. Vasc Health Risk Manag 2009;5:73-78
  • Wautier JL, Guillausseau PJ: Diabetes, advanced glycation endproducts and vascular disease. Vasc Med 1998;3:131-137
  • Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007;116:85-97
  • Motillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ: The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-1132
  • Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001;103:987-992
  • London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME: Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001;38:434-438
  • Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-2439
APA Akdam H, ALP A, KARAKÜTÜK N, GENCER N, Özbek Ö, Okyay P, akar h, Yenicerioglu Y (2016). Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. , 52 - 58.
Chicago Akdam Hakan,ALP ALPER,KARAKÜTÜK Nur,GENCER Nadide,Özbek Özgül,Okyay Pinar,akar harun,Yenicerioglu Yavuz Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. (2016): 52 - 58.
MLA Akdam Hakan,ALP ALPER,KARAKÜTÜK Nur,GENCER Nadide,Özbek Özgül,Okyay Pinar,akar harun,Yenicerioglu Yavuz Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. , 2016, ss.52 - 58.
AMA Akdam H,ALP A,KARAKÜTÜK N,GENCER N,Özbek Ö,Okyay P,akar h,Yenicerioglu Y Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. . 2016; 52 - 58.
Vancouver Akdam H,ALP A,KARAKÜTÜK N,GENCER N,Özbek Ö,Okyay P,akar h,Yenicerioglu Y Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. . 2016; 52 - 58.
IEEE Akdam H,ALP A,KARAKÜTÜK N,GENCER N,Özbek Ö,Okyay P,akar h,Yenicerioglu Y "Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients." , ss.52 - 58, 2016.
ISNAD Akdam, Hakan vd. "Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients". (2016), 52-58.
APA Akdam H, ALP A, KARAKÜTÜK N, GENCER N, Özbek Ö, Okyay P, akar h, Yenicerioglu Y (2016). Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, 25(1), 52 - 58.
Chicago Akdam Hakan,ALP ALPER,KARAKÜTÜK Nur,GENCER Nadide,Özbek Özgül,Okyay Pinar,akar harun,Yenicerioglu Yavuz Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 25, no.1 (2016): 52 - 58.
MLA Akdam Hakan,ALP ALPER,KARAKÜTÜK Nur,GENCER Nadide,Özbek Özgül,Okyay Pinar,akar harun,Yenicerioglu Yavuz Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, vol.25, no.1, 2016, ss.52 - 58.
AMA Akdam H,ALP A,KARAKÜTÜK N,GENCER N,Özbek Ö,Okyay P,akar h,Yenicerioglu Y Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi. 2016; 25(1): 52 - 58.
Vancouver Akdam H,ALP A,KARAKÜTÜK N,GENCER N,Özbek Ö,Okyay P,akar h,Yenicerioglu Y Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi. 2016; 25(1): 52 - 58.
IEEE Akdam H,ALP A,KARAKÜTÜK N,GENCER N,Özbek Ö,Okyay P,akar h,Yenicerioglu Y "Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients." Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, 25, ss.52 - 58, 2016.
ISNAD Akdam, Hakan vd. "Metabolic Syndrome and Arterial Stiffness in Peritoneal Dialysis Patients". Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 25/1 (2016), 52-58.